Yunnan Jianzhijia Health-Chain Co., Ltd.
SSE:605266.SS
22.23 (CNY) • At close June 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2017 Q2 | 2017 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 2,294.217 | 2,571.234 | 2,250.082 | 2,158.39 | 2,303.14 | 2,581.111 | 2,161.861 | 2,170.851 | 2,166.874 | 2,805.483 | 1,702.769 | 1,555.909 | 1,450.283 | 1,568.381 | 1,287.177 | 1,212.448 | 1,166.949 | 1,279.957 | 1,077.572 | 1,053.136 | 1,055.692 | 1,026.183 | 538.812 | 538.812 |
| Cost of Revenue
| 1,491.284 | 1,420.576 | 1,422.346 | 1,597.801 | 1,518.785 | 1,655.015 | 1,339.926 | 1,367.653 | 1,460.182 | 1,811.365 | 1,063.282 | 959.737 | 964.525 | 988.287 | 826.825 | 775.931 | 768.07 | 826.538 | 709.496 | 708.858 | 716.602 | 700.475 | 344.097 | 344.097 |
| Gross Profit
| 802.933 | 1,150.658 | 827.736 | 560.589 | 784.355 | 926.096 | 821.934 | 803.199 | 706.693 | 994.118 | 639.487 | 596.171 | 485.758 | 580.094 | 460.352 | 436.517 | 398.879 | 453.42 | 368.076 | 344.278 | 339.09 | 325.708 | 194.715 | 194.715 |
| Gross Profit Ratio
| 0.35 | 0.448 | 0.368 | 0.26 | 0.341 | 0.359 | 0.38 | 0.37 | 0.326 | 0.354 | 0.376 | 0.383 | 0.335 | 0.37 | 0.358 | 0.36 | 0.342 | 0.354 | 0.342 | 0.327 | 0.321 | 0.317 | 0.361 | 0.361 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 65.479 | -104.541 | 157.175 | -22.62 | 53.115 | -84.492 | 113.488 | -20.774 | 43.409 | -48.717 | 92.836 | -7.455 | 34.015 | -44.465 | 76.317 | -9.009 | 30.303 | -36.375 | 66.063 | -9.402 | 22.66 | -33.415 | 12.996 | 12.996 |
| Selling & Marketing Expenses
| 666.678 | -1,253.31 | 1,320.228 | 654.45 | 642.949 | 676.863 | 597.919 | 583.166 | 532.538 | 637.467 | 451.045 | 430.626 | 391.63 | 408.722 | 331.164 | 314.638 | 285.12 | 284.873 | 265.956 | 238.756 | 250.909 | 226.163 | 92.576 | 92.576 |
| SG&A
| 732.157 | -1,206.99 | 1,477.402 | 480.969 | 696.064 | 592.37 | 711.407 | 562.391 | 575.947 | 588.75 | 543.88 | 423.171 | 425.645 | 364.257 | 407.481 | 305.629 | 315.423 | 248.499 | 332.019 | 229.353 | 273.569 | 192.748 | 165.176 | 165.176 |
| Other Expenses
| 31.076 | 1,724.116 | 0 | -24.805 | 0.503 | 2.73 | -0.348 | 0.159 | -0.703 | 148.038 | -46.117 | 48.904 | -2.719 | 5.539 | -0 | -1.561 | 0.463 | -4.121 | -0.686 | 14.6 | -1.597 | -1.31 | 0 | 0 |
| Operating Expenses
| 763.233 | 1,165.611 | 779.811 | 505.773 | 696.064 | 736.819 | 645.703 | 628.547 | 575.244 | 736.788 | 497.763 | 472.075 | 422.926 | 446.382 | 361.963 | 345.628 | 311.05 | 352.514 | 293.328 | 271.337 | 271.374 | 264.338 | 169.887 | 169.887 |
| Operating Income
| 39.7 | -35.79 | 68.762 | 54.815 | 88.291 | 164.399 | 148.508 | 109.793 | 99.383 | 202.714 | 117.62 | 82.607 | 42.443 | 120.21 | 88.483 | 67.628 | 77.466 | 98.234 | 72.645 | 56.132 | 65.296 | 56.867 | 25.703 | 25.703 |
| Operating Income Ratio
| 0.017 | -0.014 | 0.031 | 0.025 | 0.038 | 0.064 | 0.069 | 0.051 | 0.046 | 0.072 | 0.069 | 0.053 | 0.029 | 0.077 | 0.069 | 0.056 | 0.066 | 0.077 | 0.067 | 0.053 | 0.062 | 0.055 | 0.048 | 0.048 |
| Total Other Income Expenses Net
| 0.158 | 76.249 | -21.532 | -34.052 | -27.796 | 2.73 | -0.348 | 0.159 | -1.928 | -36.089 | -23.164 | -0.036 | -27.181 | 5.539 | -9.807 | -1.561 | -9.9 | 1.622 | -0.686 | 14.6 | -1.597 | 1.263 | -1.369 | -1.369 |
| Income Before Tax
| 39.858 | 40.459 | 47.23 | 20.764 | 60.494 | 167.128 | 148.16 | 109.952 | 97.455 | 204.952 | 117.566 | 82.571 | 35.65 | 125.75 | 88.483 | 66.067 | 77.929 | 94.113 | 71.959 | 70.732 | 63.698 | 55.557 | 24.334 | 24.334 |
| Income Before Tax Ratio
| 0.017 | 0.016 | 0.021 | 0.01 | 0.026 | 0.065 | 0.069 | 0.051 | 0.045 | 0.073 | 0.069 | 0.053 | 0.025 | 0.08 | 0.069 | 0.054 | 0.067 | 0.074 | 0.067 | 0.067 | 0.06 | 0.054 | 0.045 | 0.045 |
| Income Tax Expense
| 6.314 | 10.872 | 9.703 | 11.805 | 8.609 | 29.994 | 26.671 | 29.564 | 21.981 | 32.988 | 12.91 | 24.153 | 7.296 | 21.127 | 14.714 | 8.937 | 14.194 | 14.384 | 12.761 | 13.604 | 10.343 | 12.068 | 4.738 | 4.738 |
| Net Income
| 33.526 | 27.296 | 37.952 | 10.62 | 52.26 | 135.974 | 120.347 | 81.787 | 76.304 | 170.594 | 104.761 | 58.632 | 31.315 | 104.231 | 73.805 | 57.75 | 64.742 | 80.058 | 59.907 | 57.65 | 53.533 | 44.068 | 19.825 | 19.825 |
| Net Income Ratio
| 0.015 | 0.011 | 0.017 | 0.005 | 0.023 | 0.053 | 0.056 | 0.038 | 0.035 | 0.061 | 0.062 | 0.038 | 0.022 | 0.066 | 0.057 | 0.048 | 0.055 | 0.063 | 0.056 | 0.055 | 0.051 | 0.043 | 0.037 | 0.037 |
| EPS
| 0.22 | 0.1 | 0.25 | 0.07 | 0.41 | 1.08 | 0.94 | 0.49 | 0.6 | 1.35 | 1.53 | 0.86 | 0.46 | 0.75 | 1.07 | 0.84 | 0.56 | 1.16 | 0.87 | 1.12 | 0.61 | 0.85 | 0.23 | 0.23 |
| EPS Diluted
| 0.22 | 0.1 | 0.25 | 0.07 | 0.41 | 1.06 | 0.94 | 0.49 | 0.6 | 1.35 | 1.53 | 0.86 | 0.46 | 0.75 | 1.07 | 0.84 | 0.56 | 1.16 | 0.87 | 1.12 | 0.61 | 0.85 | 0.23 | 0.23 |
| EBITDA
| 70.088 | 631.129 | 81.587 | 309.41 | 110.846 | 429.928 | 404.683 | 352.759 | 338.24 | 432.829 | 331.592 | 269.358 | 219.371 | 286.332 | 249.318 | 191.679 | 203.54 | 98.82 | 80.649 | 64.633 | 64.656 | 56.647 | 29.548 | 29.548 |
| EBITDA Ratio
| 0.031 | 0.245 | 0.036 | 0.143 | 0.048 | 0.167 | 0.187 | 0.162 | 0.156 | 0.154 | 0.195 | 0.173 | 0.151 | 0.183 | 0.194 | 0.158 | 0.174 | 0.077 | 0.075 | 0.061 | 0.061 | 0.055 | 0.055 | 0.055 |